1. Assessing the Immunogenicity of Biopharmaceuticals;C Pineda;BioDrugs,2016
2. The Global Use of Medicines: Outlook through 2017: IMS Institute for Healthcare Informatics; [cited 2017 April 24, 2017]. Available from: https://www.imshealth.com/files/web/IMSH Institute/Reports/The_Global_Use_of_Medicines_2017/global use of med 2017 right6 Biologics_Market.pdf.
3. The new world of biosimilars: what diabetologists need to know about biosimilar insulins;I Kramer;Br J Diabetes Vasc Dis,2010
4. Human Insulin Market by Product (Drug and Drug Delivery Devices) for Type 1 Diabetes, Type 2 Diabetes Application—Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015–2021: Zion Market Research; 2016 [cited 2018 January 29, 2018]. Available from: https://www.zionmarketresearch.com/report/human-insulin-market.
5. FDA approves Admelog, the first short-acting "follow-on" insulin product to treat diabetes: U.S. Food and Drug Administration; 2017 [updated December 14, 2017; cited 2018 January 29, 2018]. Available from: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm588466.htm.